Name: UMIN ID:
Unique ID issued by UMIN | UMIN000039482 |
---|---|
Receipt number | R000045019 |
Scientific Title | A Phase 3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients with Autosomal Dominant Polycystic Kidney Disease |
Date of disclosure of the study information | 2020/02/14 |
Last modified on | 2024/02/06 09:36:11 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2020/02/14 14:36:22 | ||
2 | Update | 2020/05/22 18:45:41 | Institutions |
|
3 | Update | 2020/06/10 13:20:27 | Institutions |
|
4 | Update | 2020/10/16 16:28:32 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
5 | Update | 2020/10/16 16:39:17 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
6 | Update | 2020/10/16 16:42:15 | Last follow-up date |
|
7 | Update | 2021/05/20 17:47:00 | Key inclusion criteria Key inclusion criteria Target sample size |
|
8 | Update | 2021/05/20 17:48:09 | Last follow-up date |
|
9 | Update | 2021/05/24 18:25:22 | Institutions |
|
10 | Update | 2024/02/05 11:36:09 | Last follow-up date Date of closure to data entry Date analysis concluded |
|
11 | Update | 2024/02/05 11:51:09 | Recruitment status |
|
12 | Update | 2024/02/06 09:36:11 | Number of participants that the trial has enrolled |